Cardiol Therapeutics's total assets for Q3 2025 were C$12.95M, a decrease of -35.06% from the previous quarter. TSE:CRDL total liabilities were C$3.39M for the fiscal quarter, a -58.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.